Truncating Apc mutations promote clonal growth during tumour initiation while also suppressing the growth of wild-type (WT) neighbours through WNT pathway inhibition7–9—a form of ‘supercompetitor’ behaviour. The gene discussed is APC; the disease is neoplasm.